Updated Jul 16, 2026
Menzel Garry E has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Menzel Garry E is named in SEC filings associated with Black Diamond Therapeutics, Inc. as of 2026-06-29. The available context does not specify his official title, responsibilities, or biographical details. He appears to be a corporate insider or executive tied to Black Diamond Therapeutics in those filings. For a precise role and background, the specific SEC filing (e.g., Form 4, DEF 14A, or other insider/ownership form) or the company’s leadership page should be consulted.
| Role | Insider |
|---|---|
| Notability | 20/100 |
Menzel Garry E is named in SEC filings associated with Black Diamond Therapeutics, Inc. as of 2026-06-29. The available context does not specify his official title, responsibilities, or biographical details. He appears to be a corporate insider or executive tied to Black Diamond Therapeutics in those filings. For a precise role and background, the specific SEC filing (e.g., For…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Menzel Garry E profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.